Trigeminal Neuralgia Electrophysiology
Trigeminal Evoked Responses to Improve Rhizotomy
1 other identifier
observational
30
1 country
1
Brief Summary
The study intervention is to perform standard somatosensory evoked responses limited to the face during rhizotomy procedures of the gasserian ganglion (trigeminal ganglion) for the treatment of trigeminal neuralgia. The evoked responses will be measured at two locations before and after the clinical rhizotomy including: the standard contralateral scalp (EEG) and at the gasserian ganglion through an FDA-approved recording electrode.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2022
CompletedFirst Posted
Study publicly available on registry
March 8, 2022
CompletedStudy Start
First participant enrolled
April 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 7, 2027
November 19, 2025
November 1, 2025
5 years
February 24, 2022
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determine the feasibility of measuring trigeminal somatosensory evoked potentials to improve personalized mapping during percutaneous rhizotomy
percentage of consented participants who complete the study
3 years
Study Arms (2)
Trigeminal Electrophysiology
Controls
Interventions
This study will pilot and test the feasibility of introducing electrophysiology into the routine rhizotomy procedure by including trigeminal somatosensory evoked potentials (TSEPs) and recording from electrodes at the level of the ganglion.
Eligibility Criteria
Adults of 18 years or older who are scheduled to undergo percutaneous rhizotomy for facial pain
You may qualify if:
- Adults of 18 years or older
- Scheduled to undergo percutaneous rhizotomy for facial pain
You may not qualify if:
- Facial pain of unclear origin (i.e. not clearly TGN pain)
- Rhizotomy procedure canceled
- Adults of 18 years or older
- Diagnosis or history of facial pain such as TMD or TGN
- History of migraine
- History of any functional pain disorder: fibromyalgia, IBS, CRPS
- Recent chronic pain (within last month)
- Unwilling to participate for two hours in lab
- Current acute pain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Darrow
University of Minnesota
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2022
First Posted
March 8, 2022
Study Start
April 4, 2022
Primary Completion (Estimated)
April 7, 2027
Study Completion (Estimated)
April 7, 2027
Last Updated
November 19, 2025
Record last verified: 2025-11